Literature DB >> 24976773

Dual effects of melatonin on uterine myoelectrical activity of non-pregnant rats.

Yavuz Simşek1, Hakan Parlakpınar2, Uğur Turhan3, Mehmet Emin Tağluk4, Burhan Ateş5.   

Abstract

OBJECTIVE: In this experimental study, we aimed to investigate the role of melatonin on uterine myoelectrical activity of non-pregnant rats.
MATERIAL AND METHODS: Forty-six female rats were assigned to six groups: (1) control; (0.2 mL 0.9% NaCl was injected intravenously (IV), n=6); (2) melatonin applied as 0.4 mg/kg/IV (n=8); (3) melatonin applied as 4 mg/kg/IV (n=8); (4) single dose of oxytocin (100 mU/kg) injected IV (n=8); (5) melatonin (0.4 mg/kg) plus oxytocin (100 mU/kg) (n=8); and (6) melatonin (4 mg/kg) plus oxytocin (100 mU/kg) injected IV (n=8). Each rat underwent a laparotomy, and uterine myoelectrical signals were recorded. The mean spectrum, averaged over the spectral content of signals in each group, was compared.
RESULTS: Melatonin induced uterine myoelectrical activity in a dose-dependent manner. Treatment of melatonin after oxytocin suppressed the mean power of the signals. Serum melatonin concentrations were significantly higher in melatonin-treated rats.
CONCLUSION: Melatonin itself at two different dose levels was found to be equally effective in stimulating the uterine electrical signals, although oxytocin-induced uterine electrical activity was suppressed by melatonin. These findings merit further investigations on the possible beneficial role of melatonin in the treatment of conditions associated with abnormal uterine activity.

Entities:  

Keywords:  Uterine contraction; electrical stimulation; melatonin; oxytocin

Year:  2014        PMID: 24976773      PMCID: PMC4072556          DOI: 10.5152/jtgga.2014.26932

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  27 in total

Review 1.  Melatonin: new applications in clinical and veterinary medicine, plant physiology and industry.

Authors:  Russel J Reiter; Ana Coto-Montes; Jose Antonio Boga; Lorena Fuentes-Broto; Sergio Rosales-Corral; Duan-Xian Tan
Journal:  Neuro Endocrinol Lett       Date:  2011       Impact factor: 0.765

Review 2.  Prematurity: an overview and public health implications.

Authors:  Marie C McCormick; Jonathan S Litt; Vincent C Smith; John A F Zupancic
Journal:  Annu Rev Public Health       Date:  2011       Impact factor: 21.981

3.  Hepatotoxic activity of toluene inhalation and protective role of melatonin.

Authors:  Ufuk Tas; Murat Ogeturk; Sedat Meydan; Ilter Kus; Tuncay Kuloglu; Necip Ilhan; Evren Kose; Mustafa Sarsilmaz
Journal:  Toxicol Ind Health       Date:  2011-02-22       Impact factor: 2.273

4.  Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms.

Authors:  Debasri Mukherjee; Sreerupa Ghose Roy; Arun Bandyopadhyay; Aindrila Chattopadhyay; Anjali Basu; Elina Mitra; Arnab Kr Ghosh; Russel J Reiter; Debasish Bandyopadhyay
Journal:  J Pineal Res       Date:  2010-03-04       Impact factor: 13.007

5.  [Circadian rhythm of pregnancy contractions].

Authors:  V Zahn; W Hattensperger
Journal:  Z Geburtshilfe Perinatol       Date:  1993 Jan-Feb

6.  Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury.

Authors:  Hakan Parlakpinar; Engin Sahna; M K Ozer; Fikret Ozugurlu; Nigar Vardi; Ahmet Acet
Journal:  J Pineal Res       Date:  2002-10       Impact factor: 13.007

7.  Melatonin receptor signaling in pregnant and nonpregnant rat uterine myocytes as probed by large conductance Ca2+-activated K+ channel activity.

Authors:  Frank Steffens; Xiao-Bo Zhou; Ulrike Sausbier; Claudia Sailer; Karin Motejlek; Peter Ruth; James Olcese; Michael Korth; Thomas Wieland
Journal:  Mol Endocrinol       Date:  2003-07-17

8.  Protective effects of melatonin on renal failure in pinealectomized rats.

Authors:  Hakan Parlakpinar; Ahmet Acet; Mehmet Gul; Eyup Altinoz; Mukaddes Esrefoglu; Cemil Colak
Journal:  Int J Urol       Date:  2007-08       Impact factor: 3.369

9.  Melatonin blocks in vitro generation of prostaglandin by the uterus and hypothalamus.

Authors:  M F Gimeno; A Landa; N Sterin-Speziale; D P Cardinali; A L Gimeno
Journal:  Eur J Pharmacol       Date:  1980-04-04       Impact factor: 4.432

10.  Melatonin metabolism in the central nervous system.

Authors:  Rüdiger Hardeland
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

View more
  1 in total

1.  Effect of Melatonin on Blood Loss After Cesarean Section: A Prospective Randomized Double-Blind Trial.

Authors:  Marzieh Beigom Khezri; Morteza Delkhosh Reihany; Talaat Dabbaghi Ghaleh; Navid Mohammadi
Journal:  J Obstet Gynaecol India       Date:  2019-04-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.